OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Molecular and pathobiological involvement of fetuin-A in the pathogenesis of NAFLD
Ojus Sardana, RK Goyal, Onkar Bedi
Inflammopharmacology (2021) Vol. 29, Iss. 4, pp. 1061-1074
Closed Access | Times Cited: 23
Ojus Sardana, RK Goyal, Onkar Bedi
Inflammopharmacology (2021) Vol. 29, Iss. 4, pp. 1061-1074
Closed Access | Times Cited: 23
Showing 23 citing articles:
The structure, biosynthesis, and biological roles of fetuin-A: A review
Endeshaw Chekol Abebe, Zelalem Tilahun Muche, Awigchew Behaile T Mariam, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 73
Endeshaw Chekol Abebe, Zelalem Tilahun Muche, Awigchew Behaile T Mariam, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 73
The Interconnection between Hepatic Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease—The Transition from an Adipocentric to Liver-Centric Approach
Milena Vesković, Nikola Šutulović, Dragan Hrnčić, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 9084-9102
Open Access | Times Cited: 28
Milena Vesković, Nikola Šutulović, Dragan Hrnčić, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 9084-9102
Open Access | Times Cited: 28
Fetuin-A: a relevant novel serum biomarker for non-invasive diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD): a retrospective case-control study
Mohamed Mahmoud Elhoseeny, Badawy A. Abdulaziz, Mohamed A. Mohamed, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Mohamed Mahmoud Elhoseeny, Badawy A. Abdulaziz, Mohamed A. Mohamed, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Influence of Adipokines on Metabolic Dysfunction and Aging
Seongjoon Park, Isao Shimokawa
Biomedicines (2024) Vol. 12, Iss. 4, pp. 873-873
Open Access | Times Cited: 4
Seongjoon Park, Isao Shimokawa
Biomedicines (2024) Vol. 12, Iss. 4, pp. 873-873
Open Access | Times Cited: 4
Role of pattern recognition receptors in the development of MASLD and potential therapeutic applications
Lili Yu, Feifei Gao, Yaoxin Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116724-116724
Open Access | Times Cited: 4
Lili Yu, Feifei Gao, Yaoxin Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116724-116724
Open Access | Times Cited: 4
Biomarkers to predict or measure steroid resistance in idiopathic nephrotic syndrome: A systematic review
Carl May, Nathan Ford, Gavin I. Welsh, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0312232-e0312232
Open Access
Carl May, Nathan Ford, Gavin I. Welsh, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0312232-e0312232
Open Access
Hepatokine and Proinflammatory Cytokine Profile in Patients with Carotid Atherosclerosis and Metabolic Dysfunction-Associated Steatotic Liver Disease
A.D. Cano-Contreras, María del Rocío Francisco, José Luis Vargas-Basurto, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 978-978
Open Access
A.D. Cano-Contreras, María del Rocío Francisco, José Luis Vargas-Basurto, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 978-978
Open Access
Predicting the efficacy of glucocorticoids in pediatric primary immune thrombocytopenia using plasma proteomics
Qingqing Cao, Haiyan Zhu, Wei Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Qingqing Cao, Haiyan Zhu, Wei Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Navigating the Link Between Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis and Cardiometabolic Syndrome
Sheila Gato, Vanessa García‐Fernández, Antonio Gil‐Gómez, et al.
European Cardiology Review (2024) Vol. 19
Open Access | Times Cited: 3
Sheila Gato, Vanessa García‐Fernández, Antonio Gil‐Gómez, et al.
European Cardiology Review (2024) Vol. 19
Open Access | Times Cited: 3
Emerging Links between Nonalcoholic Fatty Liver Disease and Neurodegeneration
Taylor J. Kelty, Ryan J. Dashek, W. David Arnold, et al.
Seminars in Liver Disease (2023) Vol. 43, Iss. 01, pp. 077-088
Closed Access | Times Cited: 7
Taylor J. Kelty, Ryan J. Dashek, W. David Arnold, et al.
Seminars in Liver Disease (2023) Vol. 43, Iss. 01, pp. 077-088
Closed Access | Times Cited: 7
Hepatokines and MASLD: The GLP1-Ras-FGF21-Fetuin-A Crosstalk as a Therapeutic Target
Ilaria Milani, Michela Codini, Gloria Guarisco, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10795-10795
Open Access | Times Cited: 2
Ilaria Milani, Michela Codini, Gloria Guarisco, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10795-10795
Open Access | Times Cited: 2
TMT-based proteomics analysis identifies the interventional mechanisms of Qijia Rougan decoction in improving hepatic fibrosis
Xiaofeng Chen, Xin Sun, Shaoxiu Ji, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117334-117334
Closed Access | Times Cited: 5
Xiaofeng Chen, Xin Sun, Shaoxiu Ji, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117334-117334
Closed Access | Times Cited: 5
Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines
Alexander A. Berezin, Zeljko Obradovic, Tetiana A. Berezina, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 516-516
Open Access | Times Cited: 4
Alexander A. Berezin, Zeljko Obradovic, Tetiana A. Berezina, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 516-516
Open Access | Times Cited: 4
Effect of rosuvastatin on sortilin and fetuin-A in type 2 diabetic patients: a randomized controlled trial
Rehab H. Werida, Ola Mohamed Elattar, Reem Abdelghafour, et al.
International Journal of Diabetes in Developing Countries (2024)
Open Access | Times Cited: 1
Rehab H. Werida, Ola Mohamed Elattar, Reem Abdelghafour, et al.
International Journal of Diabetes in Developing Countries (2024)
Open Access | Times Cited: 1
Investigating cognitive impairments and hippocampal proteome alterations in aged male rats with TAA-Induced minimal hepatic encephalopathy
Vishal Vikram Singh, Shambhu Kumar Prasad, Arup Acharjee, et al.
Biogerontology (2024) Vol. 26, Iss. 1
Closed Access | Times Cited: 1
Vishal Vikram Singh, Shambhu Kumar Prasad, Arup Acharjee, et al.
Biogerontology (2024) Vol. 26, Iss. 1
Closed Access | Times Cited: 1
Crosstalk between the liver and kidney in diabetic nephropathy
Ming Yang, Shilu Luo, Jinfei Yang, et al.
European Journal of Pharmacology (2022) Vol. 931, pp. 175219-175219
Closed Access | Times Cited: 4
Ming Yang, Shilu Luo, Jinfei Yang, et al.
European Journal of Pharmacology (2022) Vol. 931, pp. 175219-175219
Closed Access | Times Cited: 4
Health-related quality of life among acute pancreatitis patients correlates with metabolic variables and associated factors
Ojus Sardana, Pratima Kumari, Ravinder Singh, et al.
Annals of Medicine and Surgery (2022) Vol. 82
Open Access | Times Cited: 4
Ojus Sardana, Pratima Kumari, Ravinder Singh, et al.
Annals of Medicine and Surgery (2022) Vol. 82
Open Access | Times Cited: 4
Assessing the clinical and biochemical efficacy of alpha-lipoic acid in patients with non-alcoholic fatty liver disease: A randomized placebo-controlled clinical trial
Mehrangiz Ebrahimi‐Mameghani, Somayyeh Asghari, Fatemeh Naeini, et al.
Journal of Functional Foods (2024) Vol. 114, pp. 106050-106050
Open Access
Mehrangiz Ebrahimi‐Mameghani, Somayyeh Asghari, Fatemeh Naeini, et al.
Journal of Functional Foods (2024) Vol. 114, pp. 106050-106050
Open Access
Dietary coconut oil lowered circulating fetuin-A levels and hepatic expression of fetuin-A in KK/TaJcl mice
Yuzuru Iizuka, Chikako Kitagawa, T Tamura, et al.
Journal of Clinical Biochemistry and Nutrition (2024) Vol. 76, Iss. 2, pp. 131-138
Open Access
Yuzuru Iizuka, Chikako Kitagawa, T Tamura, et al.
Journal of Clinical Biochemistry and Nutrition (2024) Vol. 76, Iss. 2, pp. 131-138
Open Access
Investigating Hippocampal Proteome Dynamics in Aging Rats with Minimal Hepatic Encephalopathy via High-Resolution Mass Spectrometry
Vishal Vikram Singh, Shambhu Kumar Prasad, Arup Acharjee, et al.
Research Square (Research Square) (2024)
Open Access
Vishal Vikram Singh, Shambhu Kumar Prasad, Arup Acharjee, et al.
Research Square (Research Square) (2024)
Open Access
Transgender Women with HIV Demonstrate Unique Non-Alcoholic Fatty Liver Disease Profiles
Jordan E. Lake, Ana N. Hyatt, Han Feng, et al.
Transgender Health (2023) Vol. 9, Iss. 5, pp. 413-420
Closed Access | Times Cited: 1
Jordan E. Lake, Ana N. Hyatt, Han Feng, et al.
Transgender Health (2023) Vol. 9, Iss. 5, pp. 413-420
Closed Access | Times Cited: 1
Biomarkers to predict steroid resistance in idiopathic nephrotic syndrome: a systematic review
Carl May, Nathan Ford
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Carl May, Nathan Ford
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
The relationship between fetuin-A level and the clinical features of patients with coronary artery disease associated with iron deficiency
M. O. Konovalova, N. S. Mykhailovska
Pathologia (2023) Vol. 20, Iss. 3, pp. 231-237
Open Access
M. O. Konovalova, N. S. Mykhailovska
Pathologia (2023) Vol. 20, Iss. 3, pp. 231-237
Open Access
Effects of Fetuin and Glycolipid Metabolism on Metabolic Associated Fatty Liver Disease
开霞 杨
Advances in Clinical Medicine (2022) Vol. 12, Iss. 08, pp. 7360-7366
Closed Access
开霞 杨
Advances in Clinical Medicine (2022) Vol. 12, Iss. 08, pp. 7360-7366
Closed Access
